BioStem Technologies

BioStem Technologies is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of placenta-derived biologics. The company concentrates on producing life-changing products using its proprietary BioRetain® processing method. BioRetain® has been developed by applying the latest research in regenerative medicine, focusing on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (AATB).